Genetic Technologies $0.003
30 June 2023 at 1:49pm
High
$0.00Low
$0.00Trades
3Turnover
$1,511Volume
672,333
GENETIC TECHNOLOGIES LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $5,671,273 (1,275th) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 672,333 |
Shortsold (23-Mar) 355,000 (0.00%) (603rd) |
|
52w High $0.039 |
52w Low $0.039 |
P/E - |
EPS -0.09 |
GTG Webinar on Risk Assessment Tests for Serious Disease
GTG released this announcement to the ASX on 10 November 2022, 12:25. The announcement is not marked as price sensitive, and is 2 page(s) in length and 163.08kb in size.
You can view all announcements from GTG and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from GTG | |
|---|---|
| Notification of cessation of securities - GTG | 10 May 2023, 13:54 |
| Updated Investor Presentation and Investor Webinar | 2 May 2023, 8:59 |
| Publication Validates geneType for Melanoma Risk Assessment | 28 April 2023, 9:02 |
| GTG Webinar on Risk Assessment Tests for Serious Disease | 10 November 2022, 12:25 |
| Notification of cessation of securities - GTG | 9 November 2022, 15:59 |
| Genetype for Ovarian Cancer published in European Journal | 9 November 2022, 14:03 |
| Change of Director's Interest Notice | 9 November 2022, 12:31 |
If you were already registered, log in here.
If you were already registered, log in here.